{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T21:29:24Z","timestamp":1771536564175,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,3,2]],"date-time":"2012-03-02T00:00:00Z","timestamp":1330646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/eye.2012.25","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T13:37:35Z","timestamp":1330954655000},"page":"734-741","source":"Crossref","is-referenced-by-count":15,"title":["Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?"],"prefix":"10.1038","volume":"26","author":[{"given":"D","family":"Lockington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E C A","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Caslake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ramaesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,2]]},"reference":[{"issue":"6","key":"BFeye201225_CR1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120 (6): 701\u2013713; discussion 829\u2013830.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"BFeye201225_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labb\u00e9 A, Liang H, Pauly A, Brignole-Baudouin F . Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 2010; 29 (4): 312\u2013334.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"BFeye201225_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"PJ Pisella","year":"2002","unstructured":"Pisella PJ, Pouliquen P, Baudouin C . Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 2002; 86 (4): 418\u2013423.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"BFeye201225_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1442-9071.2008.01803.x","volume":"36","author":"M Ayaki","year":"2008","unstructured":"Ayaki M, Yaguchi S, Iwasawa A, Koide R . Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells. Clin Experiment Ophthalmol 2008; 36 (6): 553\u2013559.","journal-title":"Clin Experiment Ophthalmol"},{"issue":"2","key":"BFeye201225_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1076\/0271-3683(200002)2021-DFT085","volume":"20","author":"M De Saint Jean","year":"2000","unstructured":"De Saint Jean M, Debbasch C, Brignole F, Rat P, Warnet JM, Baudouin C . Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr Eye Res 2000; 20 (2): 85\u201394.","journal-title":"Curr Eye Res"},{"issue":"5","key":"BFeye201225_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","volume":"17","author":"EW Leung","year":"2008","unstructured":"Leung EW, Medeiros FA, Weinreb RN . Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008; 17 (5): 350\u2013355.","journal-title":"J Glaucoma"},{"issue":"6","key":"BFeye201225_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","volume":"29","author":"RD Fechtner","year":"2010","unstructured":"Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC . Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 2010; 29 (6): 618\u2013621.","journal-title":"Cornea"},{"issue":"4","key":"BFeye201225_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/bjo.2009.162495","volume":"94","author":"D Lockington","year":"2010","unstructured":"Lockington D, Macdonald E, Gregory M, Stewart P, Caslake M, Ramaesh K . Presence of free radicals in commonly used ophthalmic preparations. Br J Ophthalmol 2010; 94 (4): 525\u2013526.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"BFeye201225_CR9","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1136\/bjo.2009.171009","volume":"94","author":"D Lockington","year":"2010","unstructured":"Lockington D, Macdonald EC, Young D, Stewart P, Caslake M, Ramaesh K . Presence of free radicals in intracameral agents commonly used during cataract surgery. Br J Ophthalmol 2010; 94 (12): 1674\u20131677.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"BFeye201225_CR10","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1167\/iovs.08-3007","volume":"50","author":"NC Joyce","year":"2009","unstructured":"Joyce NC, Zhu CC, Harris DL . Relationship among oxidative stress, DNA damage, and proliferative capacity in human corneal endothelium. Invest Ophthalmol Vis Sci 2009; 50 (5): 2116\u20132122.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"BFeye201225_CR11","first-page":"305","volume":"28","author":"A Kuizenga","year":"1987","unstructured":"Kuizenga A, van Haeringen NJ, Kijlstra A . Inhibition of hydroxyl radical formation by human tears. Invest Ophthalmol Vis Sci 1987; 28 (2): 305\u2013313.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"BFeye201225_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/002215540205000306","volume":"50","author":"R Buddi","year":"2002","unstructured":"Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ . Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 2002; 50 (3): 341\u2013351.","journal-title":"J Histochem Cytochem"},{"issue":"11","key":"BFeye201225_CR13","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","volume":"112","author":"DC Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019Brien C, Hitchings RA . Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994; 112 (11): 1446\u20131454.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"BFeye201225_CR14","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1167\/iovs.07-0266","volume":"48","author":"C Baudouin","year":"2007","unstructured":"Baudouin C, Riancho L, Warnet JM, Brignole F . In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost. Invest Ophthalmol Vis Sci 2007; 48 (9): 4123\u20134128.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"BFeye201225_CR15","first-page":"619","volume":"40","author":"M De Saint Jean","year":"1999","unstructured":"De Saint Jean M, Brignole F, Bringuier AF, Bauchet A, Feldmann G, Baudouin C . Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 1999; 40 (3): 619\u2013630.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"BFeye201225_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/bjo.2010.189449","volume":"95","author":"H Liang","year":"2011","unstructured":"Liang H, Pauly A, Riancho L, Baudouin C, Brignole-Baudouin F . Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system. Br J Ophthalmol 2011; 95 (6): 869\u2013875.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"BFeye201225_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10384-010-0881-2","volume":"54","author":"K Kawase","year":"2010","unstructured":"Kawase K, Lin W, Aoyama Y, Yamamoto T, Shimazawa M, Hara H . Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells. Jpn J Ophthalmol 2010; 54 (6): 615\u2013621.","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"BFeye201225_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4265\/bio.15.143","volume":"15","author":"M Ayaki","year":"2010","unstructured":"Ayaki M, Iwasawa A, Yaguchi S, Koide R . Preserved and unpreserved 12 anti-allergic ophthalmic solutions and ocular surface toxicity: in vitro assessment in four cultured corneal and conjunctival epithelial cell lines. Biocontrol Sci 2010; 15 (4): 143\u2013148.","journal-title":"Biocontrol Sci"},{"issue":"11","key":"BFeye201225_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s12325-010-0070-1","volume":"27","author":"DA Ammar","year":"2010","unstructured":"Ammar DA, Noecker RJ, Kahook MY . Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Adv Ther 2010; 27 (11): 837\u2013845.","journal-title":"Adv Ther"},{"issue":"4","key":"BFeye201225_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/jop.2006.22.267","volume":"22","author":"A Labb\u00e9","year":"2006","unstructured":"Labb\u00e9 A, Pauly A, Liang H, Brignole-Baudouin F, Martin C, Warnet JM et al. Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study. J Ocul Pharmacol Ther 2006; 22 (4): 267\u2013278.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"BFeye201225_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/IJG.0b013e3181fc8129","volume":"21","author":"M Aihara","year":"2012","unstructured":"Aihara M, Otani SI, Kozaki J, Unoki K, Takeuchi M, Minami K et al. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost. J Glaucoma 2012; 21 (1): 60\u201364.","journal-title":"J Glaucoma"},{"key":"BFeye201225_CR22","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2147\/OPTH.S14113","volume":"4","author":"G Katz","year":"2010","unstructured":"Katz G, Springs CL, Craven ER, Montecchi-Palmer M . Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost. Clin Ophthalmol 2010; 4: 1253\u20131261.","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"BFeye201225_CR23","first-page":"2752","volume":"34","author":"G Wilson","year":"1993","unstructured":"Wilson G, Riley MV . Does topical hydrogen peroxide penetrate the cornea? Invest Ophthalmol Vis Sci 1993; 34 (9): 2752\u20132760.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"BFeye201225_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/IJG.0b013e31818fb434","volume":"18","author":"G Manni","year":"2009","unstructured":"Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA et al. The safety and efficacy of brinzolamide 1%\/timolol 0.5% fixed combination vs dorzolamide 2%\/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. J Glaucoma 2009; 18 (4): 293\u2013300.","journal-title":"J Glaucoma"},{"issue":"3","key":"BFeye201225_CR25","first-page":"623","volume":"2","author":"TK Mundorf","year":"2008","unstructured":"Mundorf TK, Rauchman SH, Williams RD, Notivol R . A patient preference comparison of Azarga (brinzolamide\/timolol fixed combination) vs Cosopt (dorzolamide\/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol 2008; 2 (3): 623\u2013628.","journal-title":"Clin Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye201225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201225","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:17:39Z","timestamp":1684430259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye201225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,2]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["BFeye201225"],"URL":"https:\/\/doi.org\/10.1038\/eye.2012.25","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,2]]}}}